UNSPSC 51372802: Quadazocine

This classification denotes an opioid receptor agonist and opiate antagonist with the molecular formula C25H37NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, X9BMD58553 chemically known as (-)-(2r,6s,11s)-1-cyclopentyl-5-(1,2,3,4,5,6-hexahydro-8-hydroxy-3,6,11-trimethyl-2,6-methano-3-benzazocin-11-yl)-3-pentanone but generally known as quadazocine, which bears US NIH Compound Identifier 115077.

UNSPSC 51372802 Quadazocine is a Commodity code nominally covering a specific opioid analgesic, but the single recent state and local opportunity posted under it involves procurement of naloxone and drug deactivation systems rather than quadazocine itself. Seminole County, Florida solicited these items through an IFB (Invitation for Bid) in mid-2026, indicating a mismatch between the code's nominal scope and the actual goods being purchased. State and local health departments and county public-health agencies appear to be the primary issuing bodies under this code, though the sparse recent activity provides limited visibility into the breadth of jurisdictions or repeat buyers.

Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year contract with an option for one-year renewal, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement required vendors to include all shipping and delivery costs, maintain standard insurance coverage, pass E-Verify compliance, and comply with potential federal requirements tied to FEMA funding. No other recent state or local opportunities appear in the data under this code, suggesting minimal current procurement activity. The geographic concentration and issuing-body mix cannot be reliably characterized from a single opportunity.